It also showed that the activation of PI3K-Akt mammalian target of rapamycin (PI3K-Akt-mTOR) pathway is of significant importance among abnormal upregulation of leukemogenesis in human acute myeloid leukemia [20]. Here, AKT1 is linked to acute myeloid leukemia.